Skip to content
Home/Companies/Biotech/BigHat Biosciences
BigHat Biosciences

BigHat Biosciences

Biotech·France·Active·4yr hold
Entry
2022
Hold
4yr
Status
Active

Who owns BigHat Biosciences?

BigHat Biosciences is a French Biotech company, currently owned by Quadrille Capital since 2022.

Hand-verified · updated 2026-09-30

Open JSON · CC-BY
Quadrille Capital
Investor
Quadrille Capital
Quadrille Technologies IV · 2021 · VC

Key facts

HQFrance
SectorBiotech
Websitewww.bighatbio.com

More from Quadrille Technologies IV

Other portfolio companies in the same fund.

Amboss
Active
HealthTechGermany· 2025
Sanas
Active
SoftwareUS· 2025
Exoticca
Exoticca
Active
HospitalitySpain· 2024
Wisetack
Active
FintechUS· 2024
Hivebrite
Hivebrite
Active
SaaSFrance· 2023
Medwing
Medwing
Active
HR TechGermany· 2023

More PE-backed in Biotech

Comparable biotech deals from other GPs.

Abbisko Healthcare
Active
The Carlyle GroupChina
Adagene
Active
General AtlanticChina
Advanced Cell Diagnostics
Active
Summit PartnersUS
Akero Therapeutics
Akero Therapeutics
Active
General AtlanticUS
Aldevron
Aldevron
Active
TA AssociatesUS
Alloy Therapeutics
Alloy Therapeutics
Active
Mubadala CapitalUS

Questions

Who owns BigHat Biosciences?

BigHat Biosciences is currently owned by Quadrille Capital, through Quadrille Technologies IV, since 2022.

When did Quadrille Capital acquire BigHat Biosciences?

Quadrille Capital acquired BigHat Biosciences in 2022.

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue